Lysophosphatidylcholine induces vascular smooth muscle relaxation through a non-nitric oxide-mediated pathway.
Answers are grounded in this paper and cite their sources.
Suggests LPC relaxes vascular smooth muscle via NO-independent mechanisms; leaves open relevance to human vascular physiology.
Lysophosphatidylcholine (LPC) is a potent endothelium-dependent vascular smooth muscle relaxant. The possibility that its action is mediated through endothelium-derived nitric oxide (EDNO), although suggestive, has not been proven. Both lysophosphatidylcholine and endothelium-derived nitric oxide relax by activating guanylate cyclase to form cyclic GMP. Based on the finding that EDNO formation is inhibited by NNA (N-omega-nitro-L-arginine), we followed cyclic GMP changes in bovine intrapulmonary arteries with LPC after incubation with NNA. Inhibition of cyclic GMP by LPC following NNA exposure would be suggestive of the production of EDNO by LPC. However, while NNA significantly inhibited accumulation of cyclic GMP after exposure to the calcium ionophore A23187 which releases EDNO, NNA failed to inhibit LPC-induced accumulation of cyclic GMP. The results indicate that LPC relaxes vascular smooth muscle through a non NO-mediated pathway.
No takes yet. Share an insight, caveat, or question.
Menon et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: